DDX41 and acute myeloid leukemia: We also tested the effect of Trp53-knockout on the growth and engraftment defects in HSPC bearing combined knockout and R525H point mutation of Ddx41, which models the mutations observed MDS/AML patients, and did not observe any rescue (Supplementary Fig. 7E, F).